Myeloproliferative neoplasms: open trials in Greece

• NCT07623161

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  Trial Treatment · Phase 3 · Takeda

  Laiko General Hospital of Athens, Athens · General Hospital of Athens - Alexandra, Athens · University General Hospital of Heraklion, Heraklion · Olympion General Clinic Patras P.C., Patras · Hippokration Hospital, Thessaloniki

  Registry updated 2026-11-06

• 2024-511309-47-00

  A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.

  Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc.

  Laiko General Hospital of Athens, Athens · University General Hospital Attikon, Athens · University General Hospital of Ioannina, Ioannina · General University Hospital of Larissa, Larissa · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki

  Registry updated 2026-09-25

• 2023-504724-25-00

  Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis

  Trial Treatment · Phase 3 · Kartos Therapeutics Inc.

  Laiko General Hospital of Athens, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Ioannina, Ioannina · General University Hospital Of Patras, Patras · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki

  Registry updated 2026-09-14

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Evaggelismos Hospital, Athens · Laiko General Hospital of Athens, Athens · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki

  Registry updated 2026-07-06

• NCT04064060

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Trial Treatment · Phase 3 · Celgene

  Aghia Sophia' Children's General Hospital of Athens, Athens · Athens · Athens · Rio Patras · Thessaloniki

  Registry updated 2026-07-01

• NCT05980806

  A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

  Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc

  University General Hospital Attikon, Athens · Laiko General Hospital of Athens, Athens · University General Hospital of Ioannina, Hematology Department, Ioannina · University General Hospital of Larissa, Hematology Department, Larissa · Georgios Papanikolaou General Hospital of Thessaloniki, Thessaloniki

  Registry updated 2026-02-12

• NCT06479135

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  Trial Treatment · Phase 3 · Kartos Therapeutics, Inc.

  General Hospital of Athens Laikon, Athens · University General Hospital Attikon, Athens · University General Hospital of Ioannina, Ioannina · University General Hospital of Patras, Pátrai · General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki

  Registry updated 2025-09-25

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error